newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Participation in H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company focused on developing therapies that harness targeted gene integration to treat or cure serious diseases, announced today that Josh Lehrer, M.D., M.Phil., chief exe